InnoCare Pharma, a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced that the first patient has been dosed in the clinical trial of novel CDH17 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results